nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—Irinotecan—colon cancer	0.2	0.402	CbGbCtD
Auranofin—ALB—Fluorouracil—colon cancer	0.192	0.386	CbGbCtD
Auranofin—ALB—Methotrexate—colon cancer	0.106	0.213	CbGbCtD
Auranofin—PRDX5—embryo—colon cancer	0.0195	0.109	CbGeAlD
Auranofin—PRDX5—epithelium—colon cancer	0.0159	0.0888	CbGeAlD
Auranofin—PRDX5—renal system—colon cancer	0.0147	0.0823	CbGeAlD
Auranofin—Colitis ulcerative—Irinotecan—colon cancer	0.0124	0.0768	CcSEcCtD
Auranofin—PRDX5—lymphoid tissue—colon cancer	0.0122	0.0684	CbGeAlD
Auranofin—PRDX5—digestive system—colon cancer	0.0121	0.0675	CbGeAlD
Auranofin—IKBKB—embryo—colon cancer	0.0115	0.0644	CbGeAlD
Auranofin—PRDX5—bone marrow—colon cancer	0.0111	0.0622	CbGeAlD
Auranofin—PRDX5—vagina—colon cancer	0.0107	0.0596	CbGeAlD
Auranofin—ALB—gall bladder—colon cancer	0.0106	0.0593	CbGeAlD
Auranofin—IKBKB—smooth muscle tissue—colon cancer	0.00906	0.0506	CbGeAlD
Auranofin—PRDX5—liver—colon cancer	0.009	0.0503	CbGeAlD
Auranofin—IKBKB—lymphoid tissue—colon cancer	0.00724	0.0405	CbGeAlD
Auranofin—IKBKB—digestive system—colon cancer	0.00715	0.04	CbGeAlD
Auranofin—PRDX5—lymph node—colon cancer	0.0069	0.0386	CbGeAlD
Auranofin—IKBKB—vagina—colon cancer	0.00632	0.0353	CbGeAlD
Auranofin—IKBKB—liver—colon cancer	0.00533	0.0298	CbGeAlD
Auranofin—IKBKB—lymph node—colon cancer	0.00409	0.0228	CbGeAlD
Auranofin—Interstitial pneumonia—Methotrexate—colon cancer	0.00324	0.02	CcSEcCtD
Auranofin—ALB—liver—colon cancer	0.00311	0.0174	CbGeAlD
Auranofin—Dermatitis exfoliative—Irinotecan—colon cancer	0.00242	0.0149	CcSEcCtD
Auranofin—Proteinuria—Capecitabine—colon cancer	0.00239	0.0148	CcSEcCtD
Auranofin—ALB—lymph node—colon cancer	0.00239	0.0133	CbGeAlD
Auranofin—Protein urine present—Capecitabine—colon cancer	0.00236	0.0146	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00228	0.0141	CcSEcCtD
Auranofin—Interstitial lung disease—Methotrexate—colon cancer	0.00221	0.0137	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00218	0.0135	CcSEcCtD
Auranofin—Melaena—Capecitabine—colon cancer	0.00205	0.0127	CcSEcCtD
Auranofin—Gingivitis—Methotrexate—colon cancer	0.00199	0.0123	CcSEcCtD
Auranofin—Pancytopenia—Vincristine—colon cancer	0.00192	0.0119	CcSEcCtD
Auranofin—Neutropenia—Vincristine—colon cancer	0.00189	0.0117	CcSEcCtD
Auranofin—Dysphagia—Fluorouracil—colon cancer	0.00189	0.0117	CcSEcCtD
Auranofin—Eosinophilia—Fluorouracil—colon cancer	0.00187	0.0115	CcSEcCtD
Auranofin—Neutropenia—Irinotecan—colon cancer	0.00184	0.0114	CcSEcCtD
Auranofin—Weight decreased—Vincristine—colon cancer	0.00183	0.0113	CcSEcCtD
Auranofin—Pancytopenia—Fluorouracil—colon cancer	0.00179	0.0111	CcSEcCtD
Auranofin—Weight decreased—Irinotecan—colon cancer	0.00178	0.011	CcSEcCtD
Auranofin—Proteinuria—Methotrexate—colon cancer	0.00178	0.011	CcSEcCtD
Auranofin—Neuropathy peripheral—Vincristine—colon cancer	0.00177	0.0109	CcSEcCtD
Auranofin—Stomatitis—Vincristine—colon cancer	0.00176	0.0109	CcSEcCtD
Auranofin—Protein urine present—Methotrexate—colon cancer	0.00176	0.0109	CcSEcCtD
Auranofin—Stomatitis—Irinotecan—colon cancer	0.00171	0.0106	CcSEcCtD
Auranofin—Jaundice—Irinotecan—colon cancer	0.00171	0.0106	CcSEcCtD
Auranofin—Glossitis—Methotrexate—colon cancer	0.0017	0.0105	CcSEcCtD
Auranofin—Hepatic enzyme increased—Methotrexate—colon cancer	0.00165	0.0102	CcSEcCtD
Auranofin—Neuropathy peripheral—Fluorouracil—colon cancer	0.00165	0.0102	CcSEcCtD
Auranofin—Stomatitis—Fluorouracil—colon cancer	0.00164	0.0101	CcSEcCtD
Auranofin—Conjunctivitis—Fluorouracil—colon cancer	0.00164	0.0101	CcSEcCtD
Auranofin—Dermatitis exfoliative—Capecitabine—colon cancer	0.00162	0.00999	CcSEcCtD
Auranofin—Agranulocytosis—Fluorouracil—colon cancer	0.00157	0.0097	CcSEcCtD
Auranofin—Melaena—Methotrexate—colon cancer	0.00153	0.00944	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00153	0.00943	CcSEcCtD
Auranofin—Visual impairment—Irinotecan—colon cancer	0.00152	0.00939	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—colon cancer	0.00147	0.00908	CcSEcCtD
Auranofin—Alopecia—Vincristine—colon cancer	0.00143	0.00884	CcSEcCtD
Auranofin—Alopecia—Irinotecan—colon cancer	0.00139	0.00861	CcSEcCtD
Auranofin—Flatulence—Irinotecan—colon cancer	0.00135	0.00836	CcSEcCtD
Auranofin—Alopecia—Fluorouracil—colon cancer	0.00134	0.00825	CcSEcCtD
Auranofin—Dysphagia—Capecitabine—colon cancer	0.00132	0.00815	CcSEcCtD
Auranofin—Anaemia—Vincristine—colon cancer	0.0013	0.00805	CcSEcCtD
Auranofin—Anaemia—Irinotecan—colon cancer	0.00127	0.00784	CcSEcCtD
Auranofin—Leukopenia—Vincristine—colon cancer	0.00126	0.0078	CcSEcCtD
Auranofin—Pancytopenia—Capecitabine—colon cancer	0.00125	0.00774	CcSEcCtD
Auranofin—Neutropenia—Capecitabine—colon cancer	0.00123	0.00762	CcSEcCtD
Auranofin—Leukopenia—Irinotecan—colon cancer	0.00123	0.00759	CcSEcCtD
Auranofin—Anaemia—Fluorouracil—colon cancer	0.00122	0.00751	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—colon cancer	0.0012	0.00744	CcSEcCtD
Auranofin—Weight decreased—Capecitabine—colon cancer	0.00119	0.00737	CcSEcCtD
Auranofin—Leukopenia—Fluorouracil—colon cancer	0.00118	0.00727	CcSEcCtD
Auranofin—Neuropathy peripheral—Capecitabine—colon cancer	0.00115	0.00712	CcSEcCtD
Auranofin—Jaundice—Capecitabine—colon cancer	0.00115	0.00708	CcSEcCtD
Auranofin—Stomatitis—Capecitabine—colon cancer	0.00115	0.00708	CcSEcCtD
Auranofin—Conjunctivitis—Capecitabine—colon cancer	0.00114	0.00706	CcSEcCtD
Auranofin—Thrombocytopenia—Vincristine—colon cancer	0.00113	0.00696	CcSEcCtD
Auranofin—Haematuria—Capecitabine—colon cancer	0.00112	0.00693	CcSEcCtD
Auranofin—Agranulocytosis—Capecitabine—colon cancer	0.0011	0.00678	CcSEcCtD
Auranofin—Thrombocytopenia—Irinotecan—colon cancer	0.0011	0.00678	CcSEcCtD
Auranofin—Anorexia—Vincristine—colon cancer	0.0011	0.00678	CcSEcCtD
Auranofin—Anorexia—Irinotecan—colon cancer	0.00107	0.0066	CcSEcCtD
Auranofin—Thrombocytopenia—Fluorouracil—colon cancer	0.00105	0.00649	CcSEcCtD
Auranofin—Anorexia—Fluorouracil—colon cancer	0.00102	0.00632	CcSEcCtD
Auranofin—Visual impairment—Capecitabine—colon cancer	0.00102	0.00629	CcSEcCtD
Auranofin—Decreased appetite—Vincristine—colon cancer	0.001	0.00618	CcSEcCtD
Auranofin—Eye disorder—Capecitabine—colon cancer	0.000987	0.0061	CcSEcCtD
Auranofin—Dyspepsia—Irinotecan—colon cancer	0.000987	0.00609	CcSEcCtD
Auranofin—Constipation—Vincristine—colon cancer	0.000984	0.00608	CcSEcCtD
Auranofin—Decreased appetite—Irinotecan—colon cancer	0.000974	0.00602	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—colon cancer	0.000972	0.00601	CcSEcCtD
Auranofin—Constipation—Irinotecan—colon cancer	0.000958	0.00592	CcSEcCtD
Auranofin—Dyspepsia—Fluorouracil—colon cancer	0.000945	0.00584	CcSEcCtD
Auranofin—Gastrointestinal pain—Vincristine—colon cancer	0.000941	0.00581	CcSEcCtD
Auranofin—Decreased appetite—Fluorouracil—colon cancer	0.000933	0.00576	CcSEcCtD
Auranofin—Alopecia—Capecitabine—colon cancer	0.000933	0.00576	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—colon cancer	0.000932	0.00576	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—colon cancer	0.000918	0.00567	CcSEcCtD
Auranofin—Gastrointestinal pain—Irinotecan—colon cancer	0.000916	0.00566	CcSEcCtD
Auranofin—Abdominal pain—Vincristine—colon cancer	0.00091	0.00562	CcSEcCtD
Auranofin—Flatulence—Capecitabine—colon cancer	0.000906	0.00559	CcSEcCtD
Auranofin—Dysgeusia—Capecitabine—colon cancer	0.0009	0.00556	CcSEcCtD
Auranofin—Abdominal pain—Irinotecan—colon cancer	0.000886	0.00547	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—colon cancer	0.000853	0.00527	CcSEcCtD
Auranofin—Urticaria—Fluorouracil—colon cancer	0.000853	0.00527	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—colon cancer	0.000851	0.00526	CcSEcCtD
Auranofin—Anaemia—Capecitabine—colon cancer	0.000849	0.00525	CcSEcCtD
Auranofin—Haematuria—Methotrexate—colon cancer	0.000835	0.00516	CcSEcCtD
Auranofin—Leukopenia—Capecitabine—colon cancer	0.000823	0.00508	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—colon cancer	0.000817	0.00505	CcSEcCtD
Auranofin—Diarrhoea—Vincristine—colon cancer	0.000787	0.00486	CcSEcCtD
Auranofin—Diarrhoea—Irinotecan—colon cancer	0.000767	0.00474	CcSEcCtD
Auranofin—Pruritus—Fluorouracil—colon cancer	0.000759	0.00469	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—colon cancer	0.000757	0.00468	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—colon cancer	0.000753	0.00467	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—PIK3CA—colon cancer	0.000736	0.00456	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—EP300—colon cancer	0.000735	0.00456	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—EP300—colon cancer	0.000735	0.00456	CbGpPWpGaD
Auranofin—Eye disorder—Methotrexate—colon cancer	0.000734	0.00454	CcSEcCtD
Auranofin—Diarrhoea—Fluorouracil—colon cancer	0.000734	0.00454	CcSEcCtD
Auranofin—Thrombocytopenia—Capecitabine—colon cancer	0.000734	0.00454	CcSEcCtD
Auranofin—Vomiting—Vincristine—colon cancer	0.000732	0.00452	CcSEcCtD
Auranofin—Rash—Vincristine—colon cancer	0.000726	0.00448	CcSEcCtD
Auranofin—Dermatitis—Vincristine—colon cancer	0.000725	0.00448	CcSEcCtD
Auranofin—Anorexia—Capecitabine—colon cancer	0.000715	0.00442	CcSEcCtD
Auranofin—Vomiting—Irinotecan—colon cancer	0.000713	0.0044	CcSEcCtD
Auranofin—Rash—Irinotecan—colon cancer	0.000707	0.00437	CcSEcCtD
Auranofin—Dermatitis—Irinotecan—colon cancer	0.000706	0.00436	CcSEcCtD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—SRC—colon cancer	0.000705	0.00437	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP3—colon cancer	0.000699	0.00433	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—NRAS—colon cancer	0.000698	0.00433	CbGpPWpGaD
Auranofin—Alopecia—Methotrexate—colon cancer	0.000694	0.00429	CcSEcCtD
Auranofin—IKBKB—IL17 signaling pathway—AKT1—colon cancer	0.000693	0.00429	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—BRAF—colon cancer	0.000685	0.00425	CbGpPWpGaD
Auranofin—Nausea—Vincristine—colon cancer	0.000684	0.00422	CcSEcCtD
Auranofin—Vomiting—Fluorouracil—colon cancer	0.000682	0.00422	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—HRAS—colon cancer	0.000681	0.00422	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—PIK3CA—colon cancer	0.000678	0.0042	CbGpPWpGaD
Auranofin—Rash—Fluorouracil—colon cancer	0.000677	0.00418	CcSEcCtD
Auranofin—Dermatitis—Fluorouracil—colon cancer	0.000676	0.00418	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—CASP3—colon cancer	0.000675	0.00418	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—CTNNB1—colon cancer	0.000674	0.00417	CbGpPWpGaD
Auranofin—Dysgeusia—Methotrexate—colon cancer	0.00067	0.00414	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—colon cancer	0.000666	0.00412	CbGpPWpGaD
Auranofin—Nausea—Irinotecan—colon cancer	0.000666	0.00411	CcSEcCtD
Auranofin—Dyspepsia—Capecitabine—colon cancer	0.00066	0.00408	CcSEcCtD
Auranofin—Decreased appetite—Capecitabine—colon cancer	0.000652	0.00403	CcSEcCtD
Auranofin—Constipation—Capecitabine—colon cancer	0.000641	0.00396	CcSEcCtD
Auranofin—Nausea—Fluorouracil—colon cancer	0.000638	0.00394	CcSEcCtD
Auranofin—Anaemia—Methotrexate—colon cancer	0.000632	0.00391	CcSEcCtD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TGFB1—colon cancer	0.00063	0.0039	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—AKT1—colon cancer	0.000629	0.0039	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—EP300—colon cancer	0.000626	0.00388	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—CCND1—colon cancer	0.000614	0.00381	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Capecitabine—colon cancer	0.000613	0.00379	CcSEcCtD
Auranofin—Leukopenia—Methotrexate—colon cancer	0.000612	0.00378	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—SRC—colon cancer	0.000609	0.00377	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—SRC—colon cancer	0.000602	0.00373	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—KRAS—colon cancer	0.000601	0.00372	CbGpPWpGaD
Auranofin—Urticaria—Capecitabine—colon cancer	0.000596	0.00368	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—HRAS—colon cancer	0.000593	0.00367	CbGpPWpGaD
Auranofin—Abdominal pain—Capecitabine—colon cancer	0.000593	0.00366	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—CASP3—colon cancer	0.000588	0.00364	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—NRAS—colon cancer	0.000586	0.00363	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—NRAS—colon cancer	0.000586	0.00363	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NRAS—colon cancer	0.000579	0.00359	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CASP3—colon cancer	0.000576	0.00357	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—colon cancer	0.000556	0.00344	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—SRC—colon cancer	0.00055	0.00341	CbGpPWpGaD
Auranofin—Thrombocytopenia—Methotrexate—colon cancer	0.000547	0.00338	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—PIK3CA—colon cancer	0.000544	0.00337	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—AKT1—colon cancer	0.000543	0.00337	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP3—colon cancer	0.000541	0.00335	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—colon cancer	0.000539	0.00334	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—colon cancer	0.000537	0.00333	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP3—colon cancer	0.000536	0.00332	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—colon cancer	0.000534	0.00331	CbGpPWpGaD
Auranofin—Anorexia—Methotrexate—colon cancer	0.000532	0.00329	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—APC—colon cancer	0.000531	0.00329	CbGpPWpGaD
Auranofin—Pruritus—Capecitabine—colon cancer	0.000531	0.00328	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—colon cancer	0.000528	0.00327	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—AKT1—colon cancer	0.000524	0.00324	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—colon cancer	0.000514	0.00319	CbGpPWpGaD
Auranofin—Diarrhoea—Capecitabine—colon cancer	0.000513	0.00317	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—colon cancer	0.000511	0.00317	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—PIK3CA—colon cancer	0.000507	0.00314	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—KRAS—colon cancer	0.000504	0.00312	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—KRAS—colon cancer	0.000504	0.00312	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—KRAS—colon cancer	0.000498	0.00309	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—PIK3CA—colon cancer	0.000494	0.00306	CbGpPWpGaD
Auranofin—Dyspepsia—Methotrexate—colon cancer	0.000492	0.00304	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR3—colon cancer	0.000491	0.00304	CbGpPWpGaD
Auranofin—Decreased appetite—Methotrexate—colon cancer	0.000485	0.003	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—AKT1—colon cancer	0.00048	0.00298	CbGpPWpGaD
Auranofin—Vomiting—Capecitabine—colon cancer	0.000477	0.00295	CcSEcCtD
Auranofin—Rash—Capecitabine—colon cancer	0.000473	0.00292	CcSEcCtD
Auranofin—Dermatitis—Capecitabine—colon cancer	0.000472	0.00292	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—colon cancer	0.000458	0.00284	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—PIK3CA—colon cancer	0.000458	0.00284	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Methotrexate—colon cancer	0.000457	0.00282	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—colon cancer	0.000457	0.00283	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—FGFR3—colon cancer	0.000454	0.00281	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—colon cancer	0.000451	0.00279	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—colon cancer	0.00045	0.00279	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—NRAS—colon cancer	0.000449	0.00278	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—colon cancer	0.000449	0.00278	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—PIK3CA—colon cancer	0.000447	0.00277	CbGpPWpGaD
Auranofin—Nausea—Capecitabine—colon cancer	0.000446	0.00275	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—AKT1—colon cancer	0.000444	0.00275	CbGpPWpGaD
Auranofin—Urticaria—Methotrexate—colon cancer	0.000444	0.00274	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—colon cancer	0.000443	0.00274	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—BRAF—colon cancer	0.000442	0.00274	CbGpPWpGaD
Auranofin—Abdominal pain—Methotrexate—colon cancer	0.000441	0.00273	CcSEcCtD
Auranofin—IKBKB—IL-1 signaling pathway—AKT1—colon cancer	0.000438	0.00271	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—AKT1—colon cancer	0.000438	0.00271	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—AKT1—colon cancer	0.000438	0.00271	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—colon cancer	0.000433	0.00268	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—HRAS—colon cancer	0.000429	0.00266	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—colon cancer	0.000429	0.00266	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL10—colon cancer	0.000425	0.00264	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—TGFB1—colon cancer	0.000425	0.00263	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—HRAS—colon cancer	0.000424	0.00262	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—colon cancer	0.000424	0.00262	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—BCL10—colon cancer	0.000409	0.00253	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—colon cancer	0.000403	0.0025	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—colon cancer	0.000401	0.00249	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—NRAS—colon cancer	0.000395	0.00245	CbGpPWpGaD
Auranofin—Pruritus—Methotrexate—colon cancer	0.000395	0.00244	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—HRAS—colon cancer	0.000387	0.0024	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—KRAS—colon cancer	0.000387	0.0024	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—colon cancer	0.000382	0.00237	CbGpPWpGaD
Auranofin—Diarrhoea—Methotrexate—colon cancer	0.000382	0.00236	CcSEcCtD
Auranofin—IKBKB—mTOR signaling pathway—AKT1—colon cancer	0.000379	0.00235	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—AKT1—colon cancer	0.000379	0.00235	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—colon cancer	0.000379	0.00235	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CASP3—colon cancer	0.000375	0.00232	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—AKT1—colon cancer	0.000374	0.00232	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—colon cancer	0.000374	0.00232	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—colon cancer	0.00037	0.00229	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DLC1—colon cancer	0.000368	0.00228	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—AKT1—colon cancer	0.000365	0.00226	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA7—colon cancer	0.000361	0.00224	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CTNNB1—colon cancer	0.000361	0.00224	CbGpPWpGaD
Auranofin—Vomiting—Methotrexate—colon cancer	0.000355	0.00219	CcSEcCtD
Auranofin—Rash—Methotrexate—colon cancer	0.000352	0.00218	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—colon cancer	0.000352	0.00217	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—colon cancer	0.000347	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LGR5—colon cancer	0.000346	0.00214	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—AKT1—colon cancer	0.000342	0.00212	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—KRAS—colon cancer	0.00034	0.00211	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—HRAS—colon cancer	0.000334	0.00207	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FGFR3—colon cancer	0.000334	0.00207	CbGpPWpGaD
Auranofin—Nausea—Methotrexate—colon cancer	0.000332	0.00205	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP3—colon cancer	0.000331	0.00205	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—HRAS—colon cancer	0.000329	0.00204	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—PIK3CA—colon cancer	0.000327	0.00203	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—SRC—colon cancer	0.000326	0.00202	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	0.000316	0.00196	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—colon cancer	0.000315	0.00195	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—colon cancer	0.000313	0.00194	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—PIK3CA—colon cancer	0.000312	0.00194	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—colon cancer	0.000312	0.00193	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—AKT1—colon cancer	0.000312	0.00193	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1A—colon cancer	0.000299	0.00185	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—colon cancer	0.000295	0.00183	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—colon cancer	0.00029	0.0018	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—colon cancer	0.000289	0.00179	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—BRAF—colon cancer	0.000289	0.00179	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—colon cancer	0.000279	0.00173	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—colon cancer	0.000278	0.00172	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NRAS—colon cancer	0.000278	0.00172	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CDKN1A—colon cancer	0.000277	0.00171	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000277	0.00171	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—colon cancer	0.000269	0.00167	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—colon cancer	0.000267	0.00166	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—colon cancer	0.000266	0.00165	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—colon cancer	0.000258	0.0016	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—colon cancer	0.000258	0.0016	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	0.000256	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—colon cancer	0.000255	0.00158	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—colon cancer	0.000254	0.00157	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—colon cancer	0.000253	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AXIN2—colon cancer	0.000249	0.00154	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL10—colon cancer	0.000248	0.00154	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—colon cancer	0.000247	0.00153	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NRAS—colon cancer	0.000246	0.00153	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—colon cancer	0.000242	0.0015	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—colon cancer	0.00024	0.00149	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—colon cancer	0.000239	0.00148	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—colon cancer	0.000237	0.00147	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	0.000235	0.00146	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—colon cancer	0.00023	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—colon cancer	0.000229	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—colon cancer	0.000228	0.00141	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—colon cancer	0.000224	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—colon cancer	0.000224	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—colon cancer	0.00022	0.00137	CbGpPWpGaD
Auranofin—ALB—Metabolism—ODC1—colon cancer	0.000219	0.00136	CbGpPWpGaD
Auranofin—ALB—Metabolism—CHST5—colon cancer	0.000219	0.00136	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—colon cancer	0.000216	0.00134	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—colon cancer	0.000212	0.00132	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—colon cancer	0.000212	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—colon cancer	0.000211	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—colon cancer	0.00021	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—colon cancer	0.000209	0.00129	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—colon cancer	0.000204	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1A—colon cancer	0.000204	0.00126	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—colon cancer	0.000203	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2L1—colon cancer	0.000199	0.00124	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—colon cancer	0.000195	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—colon cancer	0.000195	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGFR3—colon cancer	0.000191	0.00118	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—SRC—colon cancer	0.000188	0.00117	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—colon cancer	0.000186	0.00115	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NRAS—colon cancer	0.000184	0.00114	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGFR3—colon cancer	0.000183	0.00113	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRAS—colon cancer	0.000181	0.00112	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—colon cancer	0.00018	0.00112	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	0.00018	0.00112	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—colon cancer	0.000179	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	0.000172	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—colon cancer	0.000165	0.00102	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—colon cancer	0.000159	0.000986	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—colon cancer	0.000159	0.000983	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—colon cancer	0.000156	0.000967	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—colon cancer	0.000155	0.000958	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—colon cancer	0.000146	0.000903	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—colon cancer	0.000143	0.000888	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—colon cancer	0.000136	0.000841	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—colon cancer	0.000135	0.000836	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—colon cancer	0.000133	0.000822	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000123	0.000765	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	0.000122	0.000758	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	0.000119	0.000739	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—colon cancer	0.000119	0.000737	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—colon cancer	0.000117	0.000726	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—colon cancer	0.000116	0.00072	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2L1—colon cancer	0.000116	0.00072	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—colon cancer	0.000112	0.000691	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR3—colon cancer	0.000111	0.000688	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EP300—colon cancer	0.000111	0.000685	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	0.000109	0.000678	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SRC—colon cancer	0.000107	0.000666	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—colon cancer	0.000103	0.000641	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SRC—colon cancer	0.000103	0.000639	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—colon cancer	9.93e-05	0.000615	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—colon cancer	9.42e-05	0.000584	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—colon cancer	9.38e-05	0.000581	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	9.31e-05	0.000577	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—colon cancer	9.05e-05	0.000561	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.03e-05	0.000559	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—colon cancer	8.9e-05	0.000551	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—colon cancer	8.55e-05	0.000529	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—colon cancer	8.18e-05	0.000507	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—colon cancer	7.85e-05	0.000486	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	7.61e-05	0.000471	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—colon cancer	7.57e-05	0.000469	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—colon cancer	7.27e-05	0.00045	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR3—colon cancer	7.18e-05	0.000445	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.1e-05	0.00044	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—colon cancer	6.93e-05	0.000429	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—colon cancer	6.77e-05	0.000419	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—colon cancer	6.68e-05	0.000414	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—colon cancer	6.59e-05	0.000408	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EP300—colon cancer	6.49e-05	0.000402	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EP300—colon cancer	6.44e-05	0.000399	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—colon cancer	6.41e-05	0.000397	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SRC—colon cancer	6.31e-05	0.000391	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SRC—colon cancer	6.26e-05	0.000388	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BRAF—colon cancer	6.2e-05	0.000384	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—colon cancer	6.15e-05	0.000381	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—colon cancer	6.07e-05	0.000376	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—colon cancer	6.02e-05	0.000373	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.91e-05	0.000366	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—colon cancer	5.78e-05	0.000358	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMS—colon cancer	5.68e-05	0.000352	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—colon cancer	5.64e-05	0.000349	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—colon cancer	5.49e-05	0.00034	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—colon cancer	5.23e-05	0.000324	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—colon cancer	5.18e-05	0.000321	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—colon cancer	4.8e-05	0.000297	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—colon cancer	4.76e-05	0.000295	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—colon cancer	4.65e-05	0.000288	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—colon cancer	4.64e-05	0.000288	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—colon cancer	4.52e-05	0.00028	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—colon cancer	4.48e-05	0.000277	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—colon cancer	4.44e-05	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—colon cancer	4.41e-05	0.000273	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—colon cancer	4.37e-05	0.000271	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.37e-05	0.000271	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EP300—colon cancer	4.16e-05	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SRC—colon cancer	4.05e-05	0.000251	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—colon cancer	4.02e-05	0.000249	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—colon cancer	3.94e-05	0.000244	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—colon cancer	3.92e-05	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—colon cancer	3.89e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—colon cancer	3.89e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—colon cancer	3.63e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—colon cancer	3.62e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—colon cancer	3.55e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—colon cancer	3.35e-05	0.000208	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—colon cancer	3.16e-05	0.000196	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—colon cancer	3.08e-05	0.000191	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—colon cancer	2.98e-05	0.000185	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—colon cancer	2.85e-05	0.000176	CbGpPWpGaD
Auranofin—ALB—Metabolism—EP300—colon cancer	2.63e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—colon cancer	2.52e-05	0.000156	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—colon cancer	1.95e-05	0.000121	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—colon cancer	1.59e-05	9.85e-05	CbGpPWpGaD
